Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Posts Q1 Revenues of $1.2M; Cuts Loss

NEW YORK (GenomeWeb News) – Helicos BioSciences today reported first-quarter revenues of $1.2 million, up from $113,000 year over year.

The first quarter of 2009 is the first period in which the firm has ever reported product revenues, which were $963,000 for the three-month period ended March 31. The revenue came from the sale of one instrument that was shipped in 2008 and the sale of reagents to customers.

Helicos said that thus far it has installed its Helicos Genetic Analysis System at three user sites and has received commitments for two additional installations that are expected to be made during the second quarter of 2009.

Helcios' net loss dropped to $6.5 million, or $.10 per share, from $11.8 million, or $.57 per share, for the first quarter of 2008.

Its R&D costs declined 28 percent to $4.1 million from $5.7 million, while its SG&A spending fell sharply to $2.9 million from $6.2 million.

Helicos finished the quarter with $13.9 million in cash.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.